Oral composition containing egcg and lycopene
AssigneeDsm IP Asset B.V.
InventorsRegina GORALCZYK, Joseph SCHWAGER, Karin WERTZ
Life of this patent
Estimating the term…
Abstract
Composition containing the combination of (−)-epigallocatechin gallate (EGCG) and lycopene characterized in that the ratio of EGCG to lycopene is in the range of 100:1 to 1:1.
Claims4
-10. (canceled)
A method for suppressing sun-light induced collagenases comprising orally consuming a combination of (−)-epigallocatechin gallate (EGCG) and lycopene wherein the ratio of EGCG to lycopene is in the range of 25:1 to 5:1.
A method for reducing sun-light induced collagen and elastin degradation comprising orally consuming a combination of (−)-epigallocatechin gallate (EGCG) and lycopene wherein the ratio of EGCG to lycopene is in the range of 25:1 to 5:1.
A method for reducing sun-light induced wrinkling and skin aging comprising orally consuming a combination of (−)-epigallocatechin gallate (EGCG) and lycopene wherein the ratio of EGCG to lycopene is in the range of 25:1 to 5:1.
Dependencies are inferred from the claim text.